BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38656520)

  • 1. Dual-Luciferase Reporter Assay for Prescreening CRISPR (d)Cas9-Mediated Epigenetic Editing on a Plant Promoter Using Human Cells.
    Hinrichs AK; Koch A; Richter AM
    Methods Mol Biol; 2024; 2788():273-285. PubMed ID: 38656520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of Cell Lines Stably Expressing dCas9-Fusions to Address Kinetics of Epigenetic Editing.
    Goubert D; Koncz M; Kiss A; Rots MG
    Methods Mol Biol; 2018; 1767():395-415. PubMed ID: 29524148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation.
    Berkhout B; Gao Z; Herrera-Carrillo E
    Methods Mol Biol; 2021; 2167():205-224. PubMed ID: 32712922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing CRISPR-Cas9 for Epigenetic Engineering.
    Guerra-Resendez RS; Hilton IB
    Methods Mol Biol; 2022; 2518():237-251. PubMed ID: 35666449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-based epigenome editing: mechanisms and applications.
    Fadul SM; Arshad A; Mehmood R
    Epigenomics; 2023 Nov; 15(21):1137-1155. PubMed ID: 37990877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review on CRISPR/Cas-based epigenetic regulation in plants.
    Jogam P; Sandhya D; Alok A; Peddaboina V; Allini VR; Zhang B
    Int J Biol Macromol; 2022 Oct; 219():1261-1271. PubMed ID: 36057300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9 in Genome Editing and Beyond.
    Wang H; La Russa M; Qi LS
    Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a novel HEK293 luciferase reporter cell line by CRISPR/Cas9-mediated site-specific integration in the genome to explore the transcriptional regulation of the PGRN gene.
    Li Y; Li S; Li Y; Xia H; Mao Q
    Bioengineered; 2019 Dec; 10(1):98-107. PubMed ID: 31023186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cancer epigenetics with CRISPR-dCAS9: Principles and prospects.
    Rahman MM; Tollefsbol TO
    Methods; 2021 Mar; 187():77-91. PubMed ID: 32315755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notes on Functional Modules in the Assembly of CRISPR/Cas9-Mediated Epigenetic Modifiers.
    Kondrashov A; Karpova E
    Methods Mol Biol; 2021; 2198():401-428. PubMed ID: 32822047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation-independent long-term epigenetic silencing with dCRISPR/Cas9 fusion proteins.
    Ding L; Schmitt LT; Brux M; Sürün D; Augsburg M; Lansing F; Mircetic J; Theis M; Buchholz F
    Life Sci Alliance; 2022 Jun; 5(6):. PubMed ID: 35288457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of gene expression by altered promoter methylation using a CRISPR/Cas9-mediated epigenetic editing system.
    Kang JG; Park JS; Ko JH; Kim YS
    Sci Rep; 2019 Aug; 9(1):11960. PubMed ID: 31427598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
    Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
    Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Single Transcript CRISPR-Cas9 System for Multiplex Genome Editing in Plants.
    Tang X; Zhong Z; Ren Q; Liu B; Zhang Y
    Methods Mol Biol; 2019; 1917():75-82. PubMed ID: 30610629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 with single guide RNA expression driven by small tRNA promoters showed reduced editing efficiency compared to a U6 promoter.
    Wei Y; Qiu Y; Chen Y; Liu G; Zhang Y; Xu L; Ding Q
    RNA; 2017 Jan; 23(1):1-5. PubMed ID: 27742910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenome editing of the CFTR-locus for treatment of cystic fibrosis.
    Kabadi AM; Machlin L; Dalal N; Lee RE; McDowell I; Shah NN; Drowley L; Randell SH; Reddy TE
    J Cyst Fibros; 2022 Jan; 21(1):164-171. PubMed ID: 34049825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a gRNA Expression and Processing Platform for Efficient CRISPR-Cas9-Based Gene Editing and Gene Silencing in Candida tropicalis.
    Li Y; Zhang L; Yang H; Xia Y; Liu L; Chen X; Shen W
    Microbiol Spectr; 2022 Jun; 10(3):e0005922. PubMed ID: 35543560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing the CRISPR-Cas9 system for targeted DNA methylation.
    Vojta A; Dobrinić P; Tadić V; Bočkor L; Korać P; Julg B; Klasić M; Zoldoš V
    Nucleic Acids Res; 2016 Jul; 44(12):5615-28. PubMed ID: 26969735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal and Spatial Epigenome Editing Allows Precise Gene Regulation in Mammalian Cells.
    Kuscu C; Mammadov R; Czikora A; Unlu H; Tufan T; Fischer NL; Arslan S; Bekiranov S; Kanemaki M; Adli M
    J Mol Biol; 2019 Jan; 431(1):111-121. PubMed ID: 30098338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single transcript unit CRISPR 2.0 systems for robust Cas9 and Cas12a mediated plant genome editing.
    Tang X; Ren Q; Yang L; Bao Y; Zhong Z; He Y; Liu S; Qi C; Liu B; Wang Y; Sretenovic S; Zhang Y; Zheng X; Zhang T; Qi Y; Zhang Y
    Plant Biotechnol J; 2019 Jul; 17(7):1431-1445. PubMed ID: 30582653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.